Syndax Pharmaceuticals (SNDX) EPS (Basic): 2015-2020
Historic EPS (Basic) for Syndax Pharmaceuticals (SNDX) over the last 6 years, with Dec 2020 value amounting to -$0.44.
- Syndax Pharmaceuticals' EPS (Basic) changed negligibly% to -$0.44 in Q4 2020 from the same period last year, while for Dec 2020 it was -$1.88, marking a year-over-year decrease of 1.62%. This contributed to the annual value of -$3.72 for FY2024, which is 24.83% down from last year.
- According to the latest figures from Q4 2020, Syndax Pharmaceuticals' EPS (Basic) is -$0.44, which was up 4.35% from -$0.46 recorded in Q3 2020.
- Over the past 5 years, Syndax Pharmaceuticals' EPS (Basic) peaked at $0.79 during Q1 2018, and registered a low of -$2.85 during Q1 2016.
- For the 3-year period, Syndax Pharmaceuticals' EPS (Basic) averaged around -$0.07, with its median value being -$0.43 (2019).
- In the last 5 years, Syndax Pharmaceuticals' EPS (Basic) spiked by 257.45% in 2018 and then tumbled by 167.09% in 2019.
- Over the past 5 years, Syndax Pharmaceuticals' EPS (Basic) (Quarterly) stood at -$0.59 in 2016, then slumped by 35.59% to -$0.80 in 2017, then soared by 187.50% to $0.70 in 2018, then slumped by 162.86% to -$0.44 in 2019, then remained steady at -$0.44 in 2020.
- Its EPS (Basic) stands at -$0.44 for Q4 2020, versus -$0.46 for Q3 2020 and -$0.42 for Q2 2020.